Inuvo is trading 6.10% up at $0.75 after no new company-specific announcement was identified for August 25, 2026; the move appears consistent with stronger broader-market sentiment.
- The Nasdaq Composite showed a 0.99% pre-market gain.
- Inuvo’s latest reported catalyst was its August 11 second-quarter release, which showed a $0.27 loss per share and $7.53 million in revenue.